⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL362849 | 1.00 | — | — | |
| SCHEMBL4318147 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4319087 | 0.96 | — | — | |
| Bromide SCHEMBL9752773 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1840679 | 0.96 | — | — | |
| Bromide SCHEMBL9752774 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL6266065 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL5551404 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL4319815 | 0.96 | — | — | |
| SCHEMBL27613149 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113461926-B | Chemical synthesis method of poly beta-hydroxy fatty acid ester | 大连理工大学 | 2022-08-02 | — | — | CN | claimed |
| CN-113461926-A | Chemical synthesis method of poly beta-hydroxy fatty acid ester | 大连理工大学 | 2021-10-01 | — | — | CN | claimed |
| US-8664228-B2 | 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases | NOVARTIS AG (CH) | 2014-03-04 | — | — | US | claimed |
| EP-2285785-B1 | 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES | NOVARTIS AG (CH) | 2012-09-05 | — | — | EP | claimed |
| WO-2009138378-A1 | 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES | NOVARTIS AG (CH) | 2009-11-19 | — | — | WO | claimed |
| US-20230303625-A1 | CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION | RA PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | US | disclosed |
| CN-113461926-B | Chemical synthesis method of poly beta-hydroxy fatty acid ester | 大连理工大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-113461926-A | Chemical synthesis method of poly beta-hydroxy fatty acid ester | 大连理工大学 | 2021-10-01 | — | — | CN | disclosed |
| US-10752624-B2 | Kinase inhibitors | ORIGENIS GMBH (DE) | 2020-08-25 | — | — | US | disclosed |
| US-20200158579-A1 | TEMPERATURE EVALUATION SYSTEM, AND ARTICLE MANAGEMENT SYSTEM IN WHICH SAME IS USED | HITACHI, LTD. (JP) | 2020-05-21 | — | — | US | disclosed |
| US-20180305356-A1 | NOVEL KINASE INHIBITORS | ORIGENIS GMBH (DE) | 2018-10-25 | — | — | US | disclosed |
| US-10000482-B2 | Kinase inhibitors | ORIGENIS GMBH (DE) | 2018-06-19 | — | — | US | disclosed |
| WO-2014060113-A1 | NOVEL KINASE INHIBITORS | ORIGENIS GMBH (DE) | 2014-04-24 | — | — | WO | disclosed |
| US-8664228-B2 | 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases | NOVARTIS AG (CH) | 2014-03-04 | — | — | US | disclosed |
| EP-2285785-B1 | 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES | NOVARTIS AG (CH) | 2012-09-05 | — | — | EP | disclosed |
| WO-2009138378-A1 | 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES | NOVARTIS AG (CH) | 2009-11-19 | — | — | WO | disclosed |
| US-7371733-B2 | Anti bacterial compounds | UTAH STATE UNIVERSITY (US) | 2008-05-13 | — | — | US | disclosed |
| EP-0246194-B1 | COMPLEXES OF IRIDIUM AND THEIR USE | CIBA-GEIGY AG (CH) | 1991-10-30 | — | — | EP | disclosed |
| US-4997964-A | CATALYSTS | CIBA-GEIGY CORPORATION (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0246194-A2 | Complexes of iridium and their use | CIBA-GEIGY AG (CH) | 1987-11-19 | — | — | EP | disclosed |